Azole compounds represented by formula I: ##STR00001## wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.

 
Web www.patentalert.com

< Heterocyclic inhibitors of MEK and methods of use thereof

> Shifting between electrode combinations in electrical stimulation device

> Flexible member energy conversion device

~ 00512